These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11329997)

  • 1. ADHD treatment in a behavioral health care carve-out: medications, providers, and service utilization.
    Stein B; Orlando M
    J Behav Health Serv Res; 2001 Feb; 28(1):30-41. PubMed ID: 11329997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mothers of children diagnosed with attention-deficit/hyperactivity disorder: health conditions and medical care utilization in periods before and after birth of the child.
    Ray GT; Croen LA; Habel LA
    Med Care; 2009 Jan; 47(1):105-14. PubMed ID: 19106738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managed behavioral health services for children under carve-out contracts.
    Gresenz CR; Liu X; Sturm R
    Psychiatr Serv; 1998 Aug; 49(8):1054-8. PubMed ID: 9712212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substitution in a Medicaid mental health carve-out: services and costs.
    Libby AM; Cuellar A; Snowden LR; Orton HD
    J Health Care Finance; 2002; 28(4):11-23. PubMed ID: 12148661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance abuse service utilization under managed care: HMOs versus carve-out plans.
    Stein B; Reardon E; Sturm R
    J Behav Health Serv Res; 1999 Nov; 26(4):451-6. PubMed ID: 10565105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health care costs of adults treated for attention-deficit/hyperactivity disorder who received alternative drug therapies.
    Wu EQ; Birnbaum HG; Zhang HF; Ivanova JI; Yang E; Mallet D
    J Manag Care Pharm; 2007 Sep; 13(7):561-9. PubMed ID: 17874862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuity in methylphenidate treatment of adults with attention-deficit/hyperactivity disorder.
    Olfson M; Marcus SC; Zhang HF; Wan GJ
    J Manag Care Pharm; 2007 Sep; 13(7):570-7. PubMed ID: 17874863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization and cost of health care services for children with attention-deficit/hyperactivity disorder.
    Guevara J; Lozano P; Wickizer T; Mell L; Gephart H
    Pediatrics; 2001 Jul; 108(1):71-8. PubMed ID: 11433056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agreement between CASA parent reports and provider records of children's ADHD services.
    Bussing R; Mason DM; Leon CE; Sinha K
    J Behav Health Serv Res; 2003; 30(4):462-9. PubMed ID: 14593669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics.
    Sikirica V; Pliszka SR; Betts KA; Hodgkins P; Samuelson T; Xie J; Erder H; Dammerman R; Robertson B; Wu EQ
    J Manag Care Pharm; 2012; 18(9):676-89. PubMed ID: 23206211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of psychiatrists, psychologists, and master's-level therapists in managed behavioral health care carve-out plans.
    Sturm R; Klap R
    Psychiatr Serv; 1999 Apr; 50(4):504-8. PubMed ID: 10211731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specialty health care, treatment patterns, and quality: the impact of a mental health carve-out on care for depression.
    Busch SH
    Health Serv Res; 2002 Dec; 37(6):1583-601. PubMed ID: 12546287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of a Step Therapy for Guanfacine Extended-Release on Medication Utilization and Health Care Expenditures Among Individuals Receiving Treatment for ADHD.
    Suehs BT; Sikirica V; Mudumby P; Dufour R; Patel NC
    J Manag Care Spec Pharm; 2015 Sep; 21(9):793-802, 802a-802i. PubMed ID: 26308226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Multimodal Intervention for Children with ADHD Reduces Inequity in Health and Education Outcomes.
    Enns JE; Randall JR; Smith M; Chateau D; Taylor C; Brownell M; Bolton JM; Burland E; Katz A; Katz LY; Nickel NC
    Can J Psychiatry; 2017 Jun; 62(6):403-412. PubMed ID: 28146649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fundamental mechanisms of managed behavioral health care.
    Mihalik G; Scherer M
    J Health Care Finance; 1998; 24(3):1-15. PubMed ID: 9502052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of attention-deficit/hyperactivity disorder and use of psychotropic medication in very young children.
    Rappley MD; Mullan PB; Alvarez FJ; Eneli IU; Wang J; Gardiner JC
    Arch Pediatr Adolesc Med; 1999 Oct; 153(10):1039-45. PubMed ID: 10520611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of ADHD treatments: findings from the multimodal treatment study of children with ADHD.
    Jensen PS; Garcia JA; Glied S; Crowe M; Foster M; Schlander M; Hinshaw S; Vitiello B; Arnold LE; Elliott G; Hechtman L; Newcorn JH; Pelham WE; Swanson J; Wells K
    Am J Psychiatry; 2005 Sep; 162(9):1628-36. PubMed ID: 16135621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mental health carve-outs: Part I.
    Allen TE
    Md Med; 2001; 2(2):26-8. PubMed ID: 11398492
    [No Abstract]   [Full Text] [Related]  

  • 20. Ten-Year Trends In Treatment Services For Children With Attention Deficit Hyperactivity Disorder Enrolled In Medicaid.
    Hoagwood KE; Kelleher K; Zima BT; Perrin JM; Bilder S; Crystal S
    Health Aff (Millwood); 2016 Jul; 35(7):1266-70. PubMed ID: 27385243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.